Dushanthi Pinnaduwage

Author

Lunenfeld-Tanenbaum Research Institute

Also Known As

D Pinnaduwage, Dushanthi Pinnaduwage

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Lunenfeld-Tanenbaum Research Institute University of Toronto Mount Sinai Hospital Public Health Ontario University Health Network

About

Dushanthi Pinnaduwage is an author at Lunenfeld-Tanenbaum Research Institute specializing in medicine, tumor biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	609
2	Cell Biology	6	6	380
3	Health Sciences	1	1	14
4	Diagnostic Sciences	1	1	14
5	Immunology	1	1	37

Dushanthi Pinnaduwage

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer Marisa G. Ponzo, Robert Lesurf, Stephanie Petkiewicz, Proceedings of the National Academy of Sciences	2009	196
Expression of the Circadian Clock Genes Pert, Per2 in Sporadic, Familial Breast Tumors Sherry L. Winter, Lucine Bosnoyan-Collins, Dushanthi Pinnaduwage, Neoplasia	2007	157
JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer Michael Reedijk, Dushanthi Pinnaduwage, Brendan C. Dickson, Breast Cancer Research and Treatment Breast OncologyMedicineBasal PhenotypeJag1 ExpressionBreast Cancer	2007	146
Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry Anna Marie Mulligan, Irene Raitman, Linda Feeley, Clinical Cancer Research	2012	136
A role for the TGFβ-Par6 polarity pathway in breast cancer progression Alicia Viloria‐Petit, Laurent David, Jun Jia, Proceedings of the National Academy of Sciences Breast Cancer MetastasisTgfβ-par6 Polarity PathwayRadiation OncologyBreast OncologySignal Transduction	2009	122
Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information Linda Feeley, Anna Marie Mulligan, Dushanthi Pinnaduwage, Modern Pathology Tp53 StatusProgesterone ReceptorBreast OncologyMedicineGynecology	2013	99
The Combination of <i>p53</i> Mutation and <i>neu/erb</i>B-2 Amplification Is Associated With Poor Survival in Node-Negative Breast Cancer Shelley B. Bull, Hilmi Özçelik, Dushanthi Pinnaduwage, Journal of Clinical Oncology	2003	99
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer Jennifer F. Knight, Robert Lesurf, Hong Zhao, Proceedings of the National Academy of Sciences	2013	73
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors Anita Bane, Dushanthi Pinnaduwage, Sarah Colby, Breast Cancer Research and Treatment	2008	56
Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers Anita Bane, Alicia Viloria‐Petit, Dushanthi Pinnaduwage, Breast Cancer Research and Treatment Clinical–pathologic SignificanceFamilial Breast CancersBreast OncologyAldh1+ PhenotypeMedicine	2013	44

Page 1